Fig. 2
Analysis of outcomes reported in the studies in step-2 evidence map database by the outcome groupsa ranked as highest priority by the stakeholder panelb. Legends: a Seven outcome groups were formed, namely ‘cardiovascular disease risks,’ ‘diabetes risks,’ ‘body weight/body composition,’ ‘appetite,’ ‘liver health,’ ‘diet quality,’ and ‘mortality.’ Note top 7 categories include mortality but no studies reporting mortality outcome were identified in our evidence-mapping database. Total outcomes included 367 outcomes in the “other” category. b Outcome groups are displayed in different colors -- Cardiovascular Disease Risks (green bubbles), Diabetes Risks (light orange bubbles), Body weight/ Body Composition (combined groups, yellow bubbles), Diet Quality (red bubbles), Appetite (pink bubbles), and Liver Health (light blue bubbles). Numeric number in each bubble shows the number of studies in each outcome category. Abbreviations: Liver health: ALT- alanine aminotransferase, AST- aspartate aminotransferase, GGT- Gamma-glutamyl transpeptidase, GOT- serum glutamic-oxaloacetic Transaminase, DNL- de novo lipogenesis, IHCL-intrahepatic content of lipid, Cardiovascular disease risk: LDL- low density lipoprotein cholesterol, HDL- high-density lipoprotein cholesterol, VLDL-very low-density lipoprotein